Compare Indo National with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -4.12
- The company has been able to generate a Return on Equity (avg) of 7.13% signifying low profitability per unit of shareholders funds
The company has declared Negative results for the last 6 consecutive quarters
Risky - Negative EBITDA
Underperformed the market in the last 1 year
Stock DNA
FMCG
INR 273 Cr (Micro Cap)
NA (Loss Making)
29
1.35%
0.09
-8.71%
0.92
Total Returns (Price + Dividend) 
Latest dividend: 5 per share ex-dividend date: Sep-19-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Indo National Ltd is Rated Strong Sell
Indo National Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 Jan 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Indo National Ltd is Rated Strong Sell
Indo National Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAre Indo National Ltd latest results good or bad?
Indo National Ltd's latest financial results for Q4 FY26 reveal significant operational challenges and a concerning trend in profitability. The company reported a net loss of ₹20.91 crores, which represents a dramatic decline compared to the previous year, with a year-on-year change of -26,237.50%. This stark loss is compounded by an operating margin of -16.91%, marking the lowest on record for the company, indicating severe margin compression and operational inefficiency. Despite a modest year-on-year revenue growth of 10.31%, reaching ₹107.12 crores, this top-line performance is overshadowed by the substantial operating losses. The operating profit before depreciation, interest, tax, and other income (PBDIT excluding other income) fell to ₹-18.11 crores, a significant deterioration from the previous year. This suggests that while revenue has seen some growth, the underlying operational performance is dee...
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Updates on Acquisition
30-May-2026 | Source : BSEAdditional investment in Medcuore Medical Solutions Private Limited
Results For The Quarter And Year Ended 31St March 2026
15-May-2026 | Source : BSEresults for the quarter and year ended 31st march 2026
Board Meeting Outcome for OUTCOME OF BOARD MEETING
15-May-2026 | Source : BSEOUTCOME OF BOARD MEETING
Corporate Actions 
No Upcoming Board Meetings
Indo National Ltd has declared 100% dividend, ex-date: 19 Sep 25
Indo National Ltd has announced 5:10 stock split, ex-date: 28 Oct 21
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 1 FIIs (0.0%)
Dwaraknath Reddy (44.1%)
Sharad Kanayalal Shah (4.22%)
29.24%
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 10.31% vs -42.51% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -26,237.50% vs -96.67% in Mar 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -3.89% vs -18.01% in Sep 2024
Growth in half year ended Sep 2025 is -98.41% vs 3,500.80% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -6.75% vs -21.48% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -104.59% vs 1,615.40% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -3.21% vs -27.03% in Mar 2025
YoY Growth in year ended Mar 2026 is -121.28% vs 1,186.49% in Mar 2025






